Evidence map›Paper›PMID 25316872›Full record

ReviewThe Journal of infectious diseases2014

Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability.

Jalaa Abdelwahab, Vance Dietz, Rudolf Eggers, Christopher Maher, Marianne Olaniran, Hardeep Sandhu, Jos Vandelaer

Abstract readReview
In one paragraph

Review in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jalaa AbdelwahabUNICEF, New York City, New York.
Vance DietzGlobal Immunization Division, CDC, Atlanta, Georgia.
Rudolf EggersWHO, Geneva, Switzerland.
Christopher MaherWHO, Geneva, Switzerland.
Marianne OlaniranUNICEF, New York City, New York.
Hardeep SandhuGlobal Immunization Division, CDC, Atlanta, Georgia.
Jos VandelaerUNICEF, New York City, New York.

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, the number of polio endemic countries has declined from 125 to 3 in 2013. Despite this remarkable achievement, ongoing circulation of wild poliovirus in polio-endemic countries and the increase in the number of circulating vaccine-derived poliovirus cases, especially those caused by type 2, is a cause for concern. The Polio Eradication and Endgame Strategic Plan 2013-2018 (PEESP) was developed and includes 4 objectives: detection and interruption of poliovirus transmission, containment and certification, legacy planning, and a renewed emphasis on strengthening routine immunization (RI) programs. This is critical for the phased withdrawal of oral poliovirus vaccine, beginning with the type 2 component, and the introduction of a single dose of inactivated polio vaccine into RI programs. This objective has inspired renewed consideration of how the GPEI and RI programs can mutually benefit one another, how the infrastructure from the GPEI can be used to strengthen RI, and how a strengthened RI can facilitate polio eradication. The PEESP is the first GPEI strategic plan that places strong and clear emphasis on the necessity of improving RI to achieve and sustain global polio eradication.

Indexed as

Disease EradicationGlobal HealthHumansImmunizationPoliomyelitisPoliovirus VaccinesPoliovirus Vaccinespolio eradicationstrengthening routine immunization

Identifiers

PMID25316872
PMCPMC10617671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.